Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03715933
Title Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Inhibrx, Inc.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.